49 Wealth Management’s Novo Nordisk NVO Stock Holding History

49 Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,413	Closed	-$733K	–	221
2025 Q4	$733K	Buy	14,413 +7,209	+100%	+$369K	0.06%	84
2025 Q3	$400K	Buy	+7,204	New	+$422K	0.04%	117
2024 Q3	–	Sell	-1,486	Closed	-$216K	–	193
2024 Q2	$216K	Sell	1,486 -111	-7%	-$14.7K	0.04%	137
2024 Q1	$204K	Buy	+1,597	New	+$190K	0.04%	115

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

49 Wealth Management's NVO Position: Q1 2026 in Review

49 Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 14,413 shares — an estimated $733K sold.

49 Wealth Management first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $733K in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

49 Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
49 Wealth Management sold 14,413 Novo Nordisk shares in Q1 2026, an estimated $733K.
49 Wealth Management first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
49 Wealth Management's Novo Nordisk position peaked at $733K in Q4 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on 49 Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.